An Independent FDA: An Idea Whose Time Is Still Coming
This article was originally published in The Pink Sheet Daily
Despite strong support from six former agency commissioners, the notion of an FDA that is independent from HHS is likely to remain theoretical, at least for the near term.
You may also be interested in...
The political spotlight on the Food & Drug Administration during the COVID-19 pandemic has renewed the long-standing debate as to whether FDA should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.
In an interview with the Pink Sheet, Scott Gottlieb agrees with other ex-commissioners that there are benefits to an independent agency, but he thinks political forces would prevent it from ever happening.
Former FDA heads reflected on instances when they experienced pressure from their higher-ups; speakers also offered praise for the job Commissioner Scott Gottlieb is doing at the agency.